<p>Treatment outcomes of 669 patients enrolled in individualized treatment for MDR-TB in Peru between February 1999 and July 2002. (Adapted from Mitnick et al., 2008) <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0058664#pone.0058664-Mitnick2" target="_blank">[20]</a>.</p
<p>Data are number (%), unless otherwise indicated.</p><p>*Treatment outcome definitions used are WH...
Background: Developing countries like India are heavily burdened with multidrug resistant tuberculos...
Background: The World Health Organization target is to reduce to zero the number of death due to Myc...
<p>Overall treatment outcome of MDR-TB patients at public hospitals in the Amhara Regional State, Se...
OBJECTIVES: The objectives of this study were to evaluate treatment in patients on current programma...
To describe the incidence of extensive drug-resistant tuberculosis (XDR-TB) reported in the Peruvian...
<p>Treatment outcomes of patients with MDR-TB in KwaZulu-Natal, South Africa (N = 1038).</p
End of treatment outcomes for MDR TB patients enrolled between May 2011 and April 2014.</p
BackgroundResistance to isoniazid is the most common form of drug-resistance in tuberculosis. Howeve...
<p>Patient recruitment and outcomes from MDR-TB treatment October 2003 to January 2005.</p
Patients treated in Peru for multidrug-resistant tuberculosis (MDR-TB) were followed-up for a median...
OBJECTIVES: The objectives of this study were to evaluate treatment in patients on current programma...
Background & objectives: The increase in the burden of multidrug-resistant tuberculosis (MDR-TB) is ...
<p>*Transferred out and not recorded 10</p><p><sup>#</sup>Not recorded 2</p><p>MDR-TB treatment outc...
A better understanding of the composition of optimal treatment regimens for multidrug-resistant tube...
<p>Data are number (%), unless otherwise indicated.</p><p>*Treatment outcome definitions used are WH...
Background: Developing countries like India are heavily burdened with multidrug resistant tuberculos...
Background: The World Health Organization target is to reduce to zero the number of death due to Myc...
<p>Overall treatment outcome of MDR-TB patients at public hospitals in the Amhara Regional State, Se...
OBJECTIVES: The objectives of this study were to evaluate treatment in patients on current programma...
To describe the incidence of extensive drug-resistant tuberculosis (XDR-TB) reported in the Peruvian...
<p>Treatment outcomes of patients with MDR-TB in KwaZulu-Natal, South Africa (N = 1038).</p
End of treatment outcomes for MDR TB patients enrolled between May 2011 and April 2014.</p
BackgroundResistance to isoniazid is the most common form of drug-resistance in tuberculosis. Howeve...
<p>Patient recruitment and outcomes from MDR-TB treatment October 2003 to January 2005.</p
Patients treated in Peru for multidrug-resistant tuberculosis (MDR-TB) were followed-up for a median...
OBJECTIVES: The objectives of this study were to evaluate treatment in patients on current programma...
Background & objectives: The increase in the burden of multidrug-resistant tuberculosis (MDR-TB) is ...
<p>*Transferred out and not recorded 10</p><p><sup>#</sup>Not recorded 2</p><p>MDR-TB treatment outc...
A better understanding of the composition of optimal treatment regimens for multidrug-resistant tube...
<p>Data are number (%), unless otherwise indicated.</p><p>*Treatment outcome definitions used are WH...
Background: Developing countries like India are heavily burdened with multidrug resistant tuberculos...
Background: The World Health Organization target is to reduce to zero the number of death due to Myc...